/Investor DB

OurCrowd — 2018 Investments

2 investments dated 2018 · listed companies and verified rows first · show all

Memedmemed.comin𝕏Sep 2018 · $70M

MeMed develops a rapid 15-minute diagnostic test using machine learning to distinguish bacterial from viral infections by analyzing immune system biomarkers.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesIsrael, IL

Eran Eden(Co-founder and CEO)in

BoardOri Hadomi(Chairman of the Board of Directors)

Co-investorsDNA CapitalHorizons VenturesMetaplanetQualcomm VenturesUnion Tech VenturesWestern Technology Investment+4 more

Morphisecmorphisec.comin𝕏Feb 2018

Morphisec provides automated moving target defense technology that continuously changes and morphs a company's digital environment to prevent advanced cyber threats.

AI & Machine LearningCybersecurityEnterprise Software

Ron Reinfeld(CEO)in

Co-investors408 VenturesARC VENTURESDTCPEvolution Equity PartnersJerusalem Venture Partners (JVP)JVP+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.